Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T) (TB-TRUST)-PLUS

NCT04717908 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT04717908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04717908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T) (TB-TRUST)-PLUS
Lead sponsor
Huashan Hospital
Phase
Not applicable
Overall status
Completed
Start date
January 20, 2021
Completion date
June 22, 2024
Enrollment
89 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

multidrug resistant tuberculosis